Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma
Clinical trial NCT06102005 · COMPLETED
Trial details
- NCT number
- NCT06102005
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2026-02-23
- Enrollment
- 685
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.